Objective: To report a case with cutaneous metastasis of bladder squamous cell carcinoma. Very few cases of skin metastases from the urinary bladder are reported in the literature.
Introduction
Bladder cancer is the fourth most common cancer among men and the tenth most common cancer among women (1) .
Approximately 50% of patients will develop local recurrence and/or metastatic disease after radical cystectomy, whereas in 30% of the cases the tumor has invaded the bladder's muscle layer at the time of diagnosis (2) . The most common metastatic sites for bladder cancer are lymph nodes, liver, lung, and bone.
The skin is an uncommon site of distant metastases (3). The overall incidence of cutaneous metastasis from primary solid visceral malignancies is 2.9% to 5.3%. The incidence of cutaneous metastasis from primary urinary malignancies is reported from 1.1% to 2.5%. The most common one is kidney cancer (3.4-4%) followed by urinary bladder cancer (0.84-3.6%) and prostate cancer (0.36-0.7%) (4) . Cutaneous metastasis of bladder cancer is a rare clinical entity. Very few cases of skin metastases from urinary bladder cancer are reported in the literature. The clinical presentation of cutaneous metastases varies and can mimic many types of skin diseases. The most common clinical pictures of cutaneous metastases from genitourinary malignancies are infiltrated plaques or nodules (5) . We report a patient who presented with solitary ulcerated and necrotic metastasis from a squamous cell carcinoma of the bladder which was treated with local excision. 
Case presentation and management

Discussion
Cutaneous metastasis from internal malignancies is a rare clinical entity and it may be the first sign of an advanced disease. The most common sites of metastatic disease from urologic malignancies include the lymph nodes, bones, liver, and lungs. Cutaneous involvement after urological malignancy is uncommon; the incidence of cutaneous metastasis from bladder malignancies ranges from 0.84% to 3.60%. Urologic cancers appear less likely to metastasize to the skin compared hematogenous spread (7). In our report, the patient has a good performance status, and cutaneous metastasis developed in the absence of a widely metastatic disease. Cutaneous metastasis seems more likely to be a result of dissemination by cutaneous lymphatics or vessels. Cutaneous metastases often develop in the locoregional skin, usually abdomen, thighs and genitalia.
The abdominal skin appears to be the most common metastatic cutaneous site (5). In our report, the metastatic site developed in the pubic region under the operative scar.
Cutaneous metastases are generally associated with carcinomas invading the bladder musculature or with a local advanced neoplasm, although the literature reports a few cases of cutaneous metastasis in early-stage bladder cancer (8) . In our case, the histopathology of the cutaneous lesion revealed squamous cell carcinoma with negative surgery margin. The pathologic data were quite consistent with the initial diagnosis that this was a squamous cell carcinoma, but the primary origin was not clear. However, the pathologic stage of cystoprostatectomy was T3N0M0, indicating that the cutaneous lesion was a metastasis of bladder cancer.
Furthermore, the cutaneous lesion emerged only two months after the radical cystoprostatectomy, which was a strong indicator demonstrating that the primary origin was in the bladder. Presence of cutaneous localization from urinary bladder cancer is highly correlated to large metastatic disease (8) . Conversely, the cutaneous lesion is the first sign of a metastatic disease. Metastatic workup did not reveal local invasion or distant metastases except the cutaneous metastatic lesion.
The prognosis of cancer cell metastasis to the skin is a poor outcome. Among patients with bladder cancer with cutaneous metastasis, the median survival is less than 12 months. However, very rare cases with extended survival have been reported (5) . Local excision, radiotherapy, chemotherapy, immunological and combination therapy have been reported in previous studies (9) . Due to the poor outcomes in these patients, the treatment options are limited and primarily supportive in nature.
In conclusion, we presented a quite rare case of cutaneous metastasis of squamous cell carcinoma, which became clinically evident 2 months after the initial radical treatment. 
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